- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 28.24M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 27.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 27.68M sh |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $70.54M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $53.06M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $156.18M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $179.78M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $253.1M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $245.26M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $172.58M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $157.49M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $348M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $361.8M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $511.97M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $551.12M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.26 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.26 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $32.53M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $25.87M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $11.41M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $13.69M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$27.92M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.98M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$4.31M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $125.89M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $113.81M |
| Revenue | Q1 2026 · Mar 31, 2026 | $160.85M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $149.06M |